Berro et al reported a score for predicting non-relapse mortality following an autologous stem cell transplant. The authors are from multiple institutions in Argentina and Spain belonging to the Grupo Argentinon de Trasplante de MedulaOsea (GATMO).
Patient selection: autologous stem cell transplant
Outcome: non-relapse mortality (NRM)
Parameters:
(1) sex
(2) age
(3) underlying disease
(4) hematopoietic cell transplant-comorbidity index (HCT-CI) of Sorror et al, from 0 to 26
Parameter
Finding
Points
sex
female
0
male
1
age
< 55 years
55 to 64 years
>= 65 years of age
2
underlying disease
multiple myeloma
Hodgkin lymphoma
non-Hodgkin lymphoma
HCT-CI
< 3
>= 3
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 6
Score
Risk Level
3-Year Non-Relapse Mortality
0 or 1
low
2.3%
2 or 3
intermediate
4.9%
4
high
14.5%
5 or 6
very high
27.4%
To read more or access our algorithms and calculators, please log in or register.
Specialty: Clinical Laboratory